Bill & Melinda Gates Foundation Inks $70M Deal With AI-Powered Firm Developing Antiviral Drugs

3 yıl önce

In July, Exscientia, a pharmatech company using an end-to-end artificial intelligence (AI) platform, received a grant from the Bill & Melinda Gates Foundation to work on a new class of COVID-19 therapeutics.